ABX Abacus Global Management, Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
ABX Stock | Fundamental Analysis & Investment Insights
NYSE
Financial Services
Insurance - Life
Current Price
Live
$8.23
Analyst Target
$13.5
+64.0%
Upside
52W High
$9.61
52W Low
$4.6
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 24, 2026
Market cap
$804.51M
P/E
164.6
ROE
3.2%
Profit margin
5.6%
Debt/Equity
0.94
Dividend yield
2.4%
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
68%
Analysis Accuracy
ABX exhibits severe financial health concerns with a Piotroski F-Score of just 2/9, indicating weak fundamental strength. Despite explosive 123.7% YoY revenue growth and a bullish analyst recommendation, profitability metrics like ROE (3.18%) and ROA (4.93%) are weak, while the current ratio (0.93) and quick ratio (0.90) suggest near-term liquidity pressure. The stock trades at a massive premium to its Graham Number of $2.24, currently priced at $8.23, and despite a low forward P/E of 8.31, the trailing P/E of 164.60 reflects recent earnings collapse. Earnings have deteriorated sharply with YoY EPS down 65%, and insider sentiment is neutral with no recent activity, raising concerns about sustainability.
Key Strengths
Exceptional YoY revenue growth of 123.70%, significantly outpacing sector average of 43.77%
High gross margin of 87.52%, indicating strong pricing power or low cost structure
Operating margin of 35.59% is robust, suggesting efficient operations
Analyst consensus is strong_buy with a high target price of $13.50 implying 64% upside
Recent quarters show a history of positive earnings surprises, with 5 out of 7 beats
Key Risks
Piotroski F-Score of 2/9 signals severe financial distress and weak profitability, leverage, and operating efficiency
Current and quick ratios below 1.0 indicate potential short-term liquidity issues
Earnings collapsing: YoY EPS growth down 65.0% and most recent Q/Q EPS down 68.2%
Trailing P/E of 164.60 is extremely high, suggesting earnings may be temporarily depressed or at risk of further decline
No Altman Z-Score available, but low Piotroski and weak liquidity ratios increase bankruptcy risk
AI Fair Value Estimate
Based on comprehensive analysis
$2.24
-72.8% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
32
Weak
20
55
30
15
40
AI Verdict
High risk, low financial health, and deteriorating earnings outweigh strong revenue growth and analyst optimism
Key drivers: Piotroski F-Score of 2, Negative EPS growth trends, Liquidity ratios below 1, Massive disconnect between current price and Graham Number
Confidence
70%
Value
20/100
Ref P/E, PEG, Graham Number
Positives
- Forward P/E of 8.31 is below sector average
- Price/Sales of 4.09 may be justifiable if growth sustains
Watchpoints
- Trailing P/E of 164.60 is dangerously high
- Current price ($8.23) is 267% above Graham Number ($2.24)
- No PEG ratio due to negative or unstable earnings
Future
55/100
Ref Growth rates
Positives
- 123.70% YoY revenue growth is exceptional
- Analyst target implies strong future earnings recovery
Watchpoints
- No YoY earnings growth data available
- Recent EPS trends show sharp decline
- Uncertainty around sustainability of revenue surge
Past
30/100
Ref Historical trends
Positives
- History of beating earnings estimates (5 of 7 quarters)
Watchpoints
- Earnings have collapsed over the past year
- 52-week performance shows high volatility with 6M gain (+61.6%) but 5Y loss (-18.6%)
- Price near 52-week high but on weakening fundamentals
Health
15/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Debt/Equity of 0.94 is below sector average of 1.75
Watchpoints
- Piotroski F-Score of 2/9 indicates severe financial weakness
- Current ratio (0.93) and quick ratio (0.90) below 1 signal liquidity risk
- ROE (3.18%) and ROA (4.93%) are very low despite high margins
Dividend
40/100
Ref Yield, Payout
Positives
- Dividend yield of 2.40% is modestly attractive
Watchpoints
- Dividend strength score of 20/100 indicates weak reliability
- Payout ratio of 0.00% suggests dividend is not earnings-backed and may be unsustainable
- No 5-year yield average or ex-dividend date available
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$8.23
Analyst Target
$13.5
Upside/Downside
+64.0%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ABX and closest competitors.
Updated 2026-01-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ABX
Abacus Global Management, Inc.
Primary
|
-18.6% | -16.5% | +11.0% | +61.6% | -3.4% | -4.0% |
|
AIO
Virtus Artificial Intelligence & Technology Opportunities Fund
Peer
|
+44.0% | +81.7% | +1.9% | +0.2% | +2.7% | -1.4% |
|
AXG
Solowin Holdings
Peer
|
-32.4% | -32.4% | +152.2% | +8.9% | -3.8% | -4.0% |
|
ATLC
Atlanticus Holdings Corporation
Peer
|
+123.3% | +89.9% | -2.2% | +13.5% | -18.2% | -6.3% |
|
AMSF
AMERISAFE, Inc.
Peer
|
+2.9% | -11.3% | -18.3% | -8.5% | +5.1% | +4.2% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
164.6
Forward P/E
8.31
PEG Ratio
N/A
P/B Ratio
1.85
P/S Ratio
4.09
EV/Revenue
5.79
EV/EBITDA
15.78
Market Cap
$804.51M
Profitability
Profit margins and return metrics
Profit Margin
5.62%
Operating Margin
35.59%
Gross Margin
87.52%
ROE
3.18%
ROA
4.92%
Growth
Revenue and earnings growth rates
Revenue Growth
+123.7%
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.94
Moderate
Current Ratio
0.93
Weak
Quick Ratio
0.9
Poor
Cash/Share
$0.88
Quarterly Earnings History
EPS performance vs analyst estimates
2026-03-26
$N/A
2025-11-06
$0.07
-22.2% surprise
2025-08-08
$0.22
+34.7% surprise
2025-05-08
$0.18
+13.9% surprise
Financial Services Sector Comparison
Comparing ABX against 208 companies in the Financial Services sector
(6 bullish, 111 neutral, 91 bearish)
P/E Ratio
164.6
This Stock
vs
30.39
Sector Avg
+441.7%
(Expensive)
Return on Equity (ROE)
3.18%
This Stock
vs
-7.57%
Sector Avg
-141.9%
(Below Avg)
Profit Margin
5.62%
This Stock
vs
83.86%
Sector Avg
-93.3%
(Weaker)
Debt to Equity
0.94
This Stock
vs
1.51
Sector Avg
-37.6%
(Less Debt)
Revenue Growth
123.7%
This Stock
vs
30.29%
Sector Avg
+308.4%
(Fast Growth)
Current Ratio
0.93
This Stock
vs
3.78
Sector Avg
-75.4%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ABX
Abacus Global Management, Inc.
|
BEARISH | $804.51M | 164.6 | 3.2% | 5.6% | $8.23 | |
|
AIO
Virtus Artificial...
|
BEARISH | $778.13M | 5.36 | -% | -% | $22.6 | |
|
AXG
Solowin Holdings
|
BEARISH | $771.41M | - | -3.7% | -90.3% | $4.11 | |
|
ATLC
Atlanticus Holdings Corporation
|
NEUTRAL | $863.22M | 10.8 | 19.6% | 23.7% | $57.01 | |
|
AMSF
AMERISAFE, Inc.
|
BEARISH | $744.24M | 15.31 | 16.9% | 16.1% | $39.19 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-06 | GANOVSKY MATTHEW | President | Gift | 1,500,000 | - |
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
STRONG_BUY
5 analysts
Piper Sandler
2025-12-23
Overweight
Overweight
Piper Sandler
2025-10-09
Overweight
Overweight
Past News Coverage
Recent headlines mentioning ABX from our newsroom.
Newest → oldest
No matching news yet.